EUVIMEDEUVIMED entdecken
Crossref

An engineered dual heterojunction enables programmable photocatalytic therapy for infected diabetic wounds

Bin Luo, Xiaoqin Hu, Meihua Zhang, Mengmeng Ming, Yangrui Chen, Fang Lan, Yao Wu

Acta Biomaterialia · 2026-09 · 222 · 605-622

DOI: 10.1016/j.actbio.2026.08.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-09. Verfasst von Bin Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Analytical and Testing Center, Sichuan University, Chengdu 610064, PR China. Electronic address: Binluo@scu.edu.cn. Hauptthemen laut MEDLINE: Wound Healing, Diabetes Mellitus, Experimental, Wound Infection, Diabetes Complications. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Sichuan University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The regeneration of diabetic wounds is severely compromised by potential bacterial infection, harsh pathological microenvironment, and impaired angiogenesis. To address these challenges, we developed a dual-interfacial heterojunction consisting of MXene, TiO2, and Ti-based metal-organic framework (MOF) anchored with Pt single atoms (abbreviated as MTM) for programmable photocatalytic therapy in infected diabetic wounds. The MXene/TiO2 Schottky interface facilitates reactive oxygen species (ROS) generation under near‑infrared light, providing potent antibacterial activity. Meanwhile, the TiO2/MOF(Pt) Z-scheme interface with electron enriched Pt single atoms drives efficient hydrogen production and glucose depletion under visible light, allowing controllable clearance of excess ROS and glucose. Significantly, the released hydrogen together with glucose consumption alleviates the inflammatory microenvironment and further promotes angiogenesis via the PI3K/AKT/eNOS signaling pathway. Both in vitro and in vivo studies confirm that MTM accelerates infected diabetic wound healing through a light‑guided cascade strategy involving antibacterial action, immunomodulation, and pro‑angiogenic effects. Collectively, this dual-interfacial heterojunction with rationally tailored photocatalytic performance offers a spatiotemporal controlled cascade therapeutic platform for infected diabetic wound repair. STATEMENT OF SIGNIFICANCE: The regeneration of diabetic wounds is severely compromised by potential bacterial infection, harsh pathological microenvironment, and impaired angiogenesis. To address these challenges, we developed a dual-interfacial heterojunction consisting of MXene, TiO2, and Ti-based metal-organic framework (MOF) anchored with Pt single atoms (abbreviated as MTM) for programmable photocatalytic therapy in infected diabetic wounds. Both in vitro and in vivo studies confirm that MTM accelerates infected diabetic wound healing through a light-guided cascade strategy involving antibacterial action, immunomodulation, and pro-angiogenic effects. Collectively, this dual-interfacial heterojunction with rationally tailored photocatalytic performance offers a spatiotemporal controlled cascade therapeutic platform for infected diabetic wound repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingDiabetes Mellitus, ExperimentalWound InfectionDiabetes ComplicationsAnimalsCatalysisAnti-Bacterial AgentsTitaniumHumansReactive Oxygen SpeciesMetal-Organic FrameworksMaleRats, Sprague-Dawley

Stichwörter der Autor:innen

AntibacterialDiabetic woundHeterojunctionImmunomodulationPhotocatalytic therapy

Substanzen

Anti-Bacterial AgentsTitaniumtitanium dioxideReactive Oxygen SpeciesMetal-Organic Frameworks

Autor:innen und Institutionen

  • Analytical and Testing Center, Sichuan University, Chengdu 610064, PR China. Electronic address: Binluo@scu.edu.cn.
  • National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, , PR China.
  • Analytical and Testing Center, Sichuan University, Chengdu 610064, PR China.
  • National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, , PR China. Electronic address: Wuyao@scu.edu.cn.

Förderung

  • Sichuan University
  • National Natural Science Foundation of China

Zitieren

APA

Luo, B., Hu, X., Zhang, M., Ming, M., Chen, Y., Lan, F., & Wu, Y. (2026). An engineered dual heterojunction enables programmable photocatalytic therapy for infected diabetic wounds. Acta Biomaterialia, 222, 605-622. https://doi.org/10.1016/j.actbio.2026.08.022

Vancouver

Luo B, Hu X, Zhang M, Ming M, Chen Y, Lan F, et al. An engineered dual heterojunction enables programmable photocatalytic therapy for infected diabetic wounds. Acta Biomaterialia. 2026;222:605-622. doi:10.1016/j.actbio.2026.08.022

BibTeX
@article{Luo2026,
  author = {Luo, Bin and Hu, Xiaoqin and Zhang, Meihua and Ming, Mengmeng and Chen, Yangrui and Lan, Fang and Wu, Yao},
  title = {An engineered dual heterojunction enables programmable photocatalytic therapy for infected diabetic wounds},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {222},
  pages = {605--622},
  doi = {10.1016/j.actbio.2026.08.022}
}
Kostenlos starten →